sefulness of homoeopathic medicines inthe management of Leptospirosis.
- Registration Number
- CTRI/2008/091/000183
- Lead Sponsor
- Director CCRH through Dept. of AYUSH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
?Patients of either sex, age group 12-45 years, presenting to study physician within 48hrs of onset of symptoms.
Patients presents with signs/symptoms Leptospirosis like illnesses: Abrupt onset of fever with severe headache, myalgia, suffusion of conjunctiva and vomiting.
Written informed consent.
Patients with signs/symptoms of jaundice, renal insufficiency, cardiac involvement, meningitis/ meningoencephalitis and pulmonary involvement.
Patients with mixed presentation, arising suspicion of a mixed infection.
Who have received other medication within the 48 hours before entry into the study.
Inability to comply with the study protocol, including psychiatric diseases, low intelligence level.
Immune compromised or with other clinically active illness. But cases of diabetes that is under control will be included.
Pregnant women.
Lactating mother.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate usefulness of homoeopathic medicines in the management of leptospirosis.Timepoint: 7 days
- Secondary Outcome Measures
Name Time Method To evaluate usefulness of homoeopathic medicines in preventing late sequel of leptospirosis in cases treated homoeopathicallyTimepoint: 7 days